Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development | Aug 2004 | £1,420 | 100% |
| Biomarkers The Expanding Global Market |
Jan 2007 | £2,760 | 98% |
| Molecular Diagnostics in Cancer Testing | Jul 2011 | £2,150 | 97% |
| Advances in Imaging Biomarkers Innovative technologies, applications in R&D and clinical practice, and informatics and regulatory requirements |
Jul 2010 | £2,425 | 96% |
| Biomarkers | Aug 2011 | £3,035 | 95% |
| Molecular Imaging in Drug R&D and Medical Practice Technologies, Applications, Markets |
Jan 2008 | £710 | 95% |
| Cytogenetics Technologies, Markets and Companies |
Jan 2012 | £1,620 | 95% |
| Biomarkers (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 94% |
| Biomarkers: Discovery Techniques and Applications A Global Market Overview |
Sep 2010 | £3,075 | 93% |
| Biomarker Technology Platforms for Cancer Diagnoses and Therapies | Sep 2011 | £2,150 | 93% |
| Biomarkers - Advanced Technologies and Global Market 2009 - 2014 |
Sep 2009 | £2,940 | 93% |
| Commercializing Molecular Diagnostics Products, Services, Companies and Global Market |
Jan 2008 | £1,640 | 92% |
| Cell Culture The World Market for Media, Sera, and Reagents |
Jan 2007 | £2,465 | 92% |
| Global Cancer Biomarkers Market (2010 - 2015) | May 2010 | £2,940 | 91% |
| Companion Diagnostics in Personalized Medicine and Cancer Therapy | Jul 2011 | £2,150 | 91% |
| Biomarkers: A Market Briefing A Market Briefing |
Jan 2007 | £1,260 | 91% |
| Cancer Personalized Medicine 2008 | Jul 2008 | £2,425 | 91% |
| Biomedical Imaging From Drug Target Discovery to Medical Diagnostics |
Dec 2008 | £2,370 | 91% |
| Cancer Profiling and Pathways Technologies and Global Markets |
Sep 2010 | £3,065 | 91% |
| Advancing Molecular Diagnostics to Personalize Cancer Therapy | Jun 2011 | £2,425 | 91% |
| Molecular Diagnostics (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,560 | 90% |
| Personalized Medicine (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 90% |
| Innovations in Oncology Diagnostics Technological advances, growth opportunities and future market outlook |
Oct 2009 | £2,425 | 89% |
| Biomarkers in Drug Discovery Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly |
Oct 2011 | £2,215 | 89% |
| Companion Diagnostics | Sep 2011 | £2,655 | 89% |
| R&D Trends: Colorectal Cancer | Jun 2011 | £1,200 | 89% |
| Biomarkers, Tests and Trends for Drug R&D | Feb 2010 | £1,390 | 88% |
| Biochips/Microarrays Technologies, Markets and Companies |
Jan 2012 | £1,555 | 87% |
| Biomarkers: The Future of Next-Generation Drug R&D | Sep 2008 | £1,640 | 87% |
| The Future of In Vitro and In Vivo Diagnostic Integration | Jan 2011 | £2,490 | 87% |
